Compile Data Set for Download or QSAR

Found 23 hits with Last Name = 'grueneberg' and Initial = 's'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Carboxypeptidase B (Homo sapiens (Human))	BDBM120796 (US8710232, 33) Show SMILES CC1(C)CCC(CC1)n1cnc(c1)C(Cc1ccc(N)nc1)C(O)=O Show InChI InChI=1S/C19H26N4O2/c1-19(2)7-5-14(6-8-19)23-11-16(22-12-23)15(18(24)25)9-13-3-4-17(20)21-10-13/h3-4,10-12,14-15H,5-9H2,1-2H3,(H2,20,21)(H,24,25)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	7.4	25
Sanofi-Aventis Deutschland GmbH US Patent					Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...				US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4
					More data for this Ligand-Target Pair
Carboxypeptidase B (Homo sapiens (Human))	BDBM120790 (US8710232, 17) Show SMILES Nc1ccc(CC(C(O)=O)c2cn(CC3CCCN(C3)C(=O)C(c3ccccc3)c3ccccc3)cn2)cn1 Show InChI InChI=1S/C31H33N5O3/c32-28-14-13-22(17-33-28)16-26(31(38)39)27-20-35(21-34-27)18-23-8-7-15-36(19-23)30(37)29(24-9-3-1-4-10-24)25-11-5-2-6-12-25/h1-6,9-14,17,20-21,23,26,29H,7-8,15-16,18-19H2,(H2,32,33)(H,38,39)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	11	n/a	n/a	n/a	n/a	7.4	25
Sanofi-Aventis Deutschland GmbH US Patent					Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...				US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4
					More data for this Ligand-Target Pair
Carboxypeptidase B (Homo sapiens (Human))	BDBM120788 (US8710232, 15) Show SMILES Nc1ccc(CC(C(O)=O)c2cn(CC3CCCCN3C(=O)c3ccccc3)cn2)cn1 Show InChI InChI=1S/C24H27N5O3/c25-22-10-9-17(13-26-22)12-20(24(31)32)21-15-28(16-27-21)14-19-8-4-5-11-29(19)23(30)18-6-2-1-3-7-18/h1-3,6-7,9-10,13,15-16,19-20H,4-5,8,11-12,14H2,(H2,25,26)(H,31,32)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	12	n/a	n/a	n/a	n/a	7.4	25
Sanofi-Aventis Deutschland GmbH US Patent					Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...				US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4
					More data for this Ligand-Target Pair
Carboxypeptidase B (Homo sapiens (Human))	BDBM120787 (US8710232, 13) Show SMILES Nc1ccc(CC(C(O)=O)c2cn(CCC3CCN(CC3)C(=O)C(c3ccccc3)c3ccccc3)cn2)cn1 Show InChI InChI=1S/C32H35N5O3/c33-29-12-11-24(20-34-29)19-27(32(39)40)28-21-36(22-35-28)16-13-23-14-17-37(18-15-23)31(38)30(25-7-3-1-4-8-25)26-9-5-2-6-10-26/h1-12,20-23,27,30H,13-19H2,(H2,33,34)(H,39,40)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	12	n/a	n/a	n/a	n/a	7.4	25
Sanofi-Aventis Deutschland GmbH US Patent					Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...				US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4
					More data for this Ligand-Target Pair
Carboxypeptidase B (Homo sapiens (Human))	BDBM120786 (US8710232, 12) Show SMILES Nc1ccc(CC(C(O)=O)c2cn(cn2)-c2ccc(NC(=O)Nc3ccccc3)cc2)cn1 Show InChI InChI=1S/C24H22N6O3/c25-22-11-6-16(13-26-22)12-20(23(31)32)21-14-30(15-27-21)19-9-7-18(8-10-19)29-24(33)28-17-4-2-1-3-5-17/h1-11,13-15,20H,12H2,(H2,25,26)(H,31,32)(H2,28,29,33)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	15	n/a	n/a	n/a	n/a	7.4	25
Sanofi-Aventis Deutschland GmbH US Patent					Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...				US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4
					More data for this Ligand-Target Pair
Carboxypeptidase B (Homo sapiens (Human))	BDBM120782 (US8710232, 7) Show SMILES Nc1ccc(CC(C(O)=O)c2cn(cn2)C2CCCC2)cn1 Show InChI InChI=1S/C16H20N4O2/c17-15-6-5-11(8-18-15)7-13(16(21)22)14-9-20(10-19-14)12-3-1-2-4-12/h5-6,8-10,12-13H,1-4,7H2,(H2,17,18)(H,21,22)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	16	n/a	n/a	n/a	n/a	7.4	25
Sanofi-Aventis Deutschland GmbH US Patent					Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...				US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4
					More data for this Ligand-Target Pair
Carboxypeptidase B (Homo sapiens (Human))	BDBM120791 (US8710232, 18) Show SMILES Nc1ccc(CC(C(O)=O)c2cn(CCC3CCN(CC3)C(=O)CCc3ccccc3)cn2)cn1 Show InChI InChI=1S/C27H33N5O3/c28-25-8-6-22(17-29-25)16-23(27(34)35)24-18-31(19-30-24)13-10-21-11-14-32(15-12-21)26(33)9-7-20-4-2-1-3-5-20/h1-6,8,17-19,21,23H,7,9-16H2,(H2,28,29)(H,34,35)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	21	n/a	n/a	n/a	n/a	7.4	25
Sanofi-Aventis Deutschland GmbH US Patent					Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...				US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4
					More data for this Ligand-Target Pair
Carboxypeptidase B (Homo sapiens (Human))	BDBM120785 (US8710232, 10) Show SMILES Nc1ccc(CC(C(O)=O)c2cn(CC(=O)NC(c3ccccc3)c3ccccc3)cn2)cn1 Show InChI InChI=1S/C26H25N5O3/c27-23-12-11-18(14-28-23)13-21(26(33)34)22-15-31(17-29-22)16-24(32)30-25(19-7-3-1-4-8-19)20-9-5-2-6-10-20/h1-12,14-15,17,21,25H,13,16H2,(H2,27,28)(H,30,32)(H,33,34)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	23	n/a	n/a	n/a	n/a	7.4	25
Sanofi-Aventis Deutschland GmbH US Patent					Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...				US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4
					More data for this Ligand-Target Pair
Carboxypeptidase B (Homo sapiens (Human))	BDBM120781 (US8710232, 1) Show SMILES Nc1ccc(CC(C(O)=O)c2cn(cn2)C2CCCCC2)cn1 Show InChI InChI=1S/C17H22N4O2/c18-16-7-6-12(9-19-16)8-14(17(22)23)15-10-21(11-20-15)13-4-2-1-3-5-13/h6-7,9-11,13-14H,1-5,8H2,(H2,18,19)(H,22,23)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	30	n/a	n/a	n/a	n/a	7.4	25
Sanofi-Aventis Deutschland GmbH US Patent					Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...				US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4
					More data for this Ligand-Target Pair
Carboxypeptidase B (Homo sapiens (Human))	BDBM120789 (US8710232, 16) Show SMILES Nc1ccc(CC(C(O)=O)c2cn(CCC3CCCN(C3)C(=O)CCc3ccccc3)cn2)cn1 Show InChI InChI=1S/C27H33N5O3/c28-25-10-8-22(16-29-25)15-23(27(34)35)24-18-31(19-30-24)14-12-21-7-4-13-32(17-21)26(33)11-9-20-5-2-1-3-6-20/h1-3,5-6,8,10,16,18-19,21,23H,4,7,9,11-15,17H2,(H2,28,29)(H,34,35)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	38	n/a	n/a	n/a	n/a	7.4	25
Sanofi-Aventis Deutschland GmbH US Patent					Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...				US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4
					More data for this Ligand-Target Pair
Carboxypeptidase B (Homo sapiens (Human))	BDBM120797 (US8710232, 37) Show SMILES CCCNC(=O)Nc1ccc(cc1)-n1cnc(c1)C(Cc1ccc(N)nc1)C(O)=O Show InChI InChI=1S/C21H24N6O3/c1-2-9-23-21(30)26-15-4-6-16(7-5-15)27-12-18(25-13-27)17(20(28)29)10-14-3-8-19(22)24-11-14/h3-8,11-13,17H,2,9-10H2,1H3,(H2,22,24)(H,28,29)(H2,23,26,30)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	49	n/a	n/a	n/a	n/a	7.4	25
Sanofi-Aventis Deutschland GmbH US Patent					Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...				US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4
					More data for this Ligand-Target Pair
Carboxypeptidase B (Homo sapiens (Human))	BDBM120784 (US8710232, 9) Show SMILES Nc1ccc(CC(C(O)=O)c2cn(cn2)C2CCN(C2=O)c2ccccc2)cn1 Show InChI InChI=1S/C21H21N5O3/c22-19-7-6-14(11-23-19)10-16(21(28)29)17-12-25(13-24-17)18-8-9-26(20(18)27)15-4-2-1-3-5-15/h1-7,11-13,16,18H,8-10H2,(H2,22,23)(H,28,29)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	439	n/a	n/a	n/a	n/a	7.4	25
Sanofi-Aventis Deutschland GmbH US Patent					Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...				US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4
					More data for this Ligand-Target Pair
Carboxypeptidase B (Homo sapiens (Human))	BDBM120795 (US8710232, 31) Show SMILES Nc1ccc(CC(C(O)=O)c2cn(CC#C)cn2)cn1 Show InChI InChI=1S/C14H14N4O2/c1-2-5-18-8-12(17-9-18)11(14(19)20)6-10-3-4-13(15)16-7-10/h1,3-4,7-9,11H,5-6H2,(H2,15,16)(H,19,20)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	870	n/a	n/a	n/a	n/a	7.4	25
Sanofi-Aventis Deutschland GmbH US Patent					Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...				US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4
					More data for this Ligand-Target Pair
C-X-C chemokine receptor type 2 (Homo sapiens (Human))	BDBM100343 (US8501981, 52) Show SMILES CC(CCc1ccccc1)Oc1c(ccc2ccccc12)C(=O)NC1(CCCC1)C(O)=O Show InChI InChI=1S/C27H29NO4/c1-19(13-14-20-9-3-2-4-10-20)32-24-22-12-6-5-11-21(22)15-16-23(24)25(29)28-27(26(30)31)17-7-8-18-27/h2-6,9-12,15-16,19H,7-8,13-14,17-18H2,1H3,(H,28,29)(H,30,31)	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	920	n/a	n/a	n/a	n/a	n/a	n/a
SANOFI US Patent					Assay Description CXCR2 inhibition using calcium fluorescence assay (FLIPR).				US Patent US8501981 (2013) BindingDB Entry DOI: 10.7270/Q24Q7SMB
					More data for this Ligand-Target Pair
Carboxypeptidase B (Homo sapiens (Human))	BDBM120793 (US8710232, 27) Show SMILES Nc1ccc(CC(C(O)=O)c2cn(Cc3csc4ccc(Cl)cc34)cn2)cn1 Show InChI InChI=1S/C20H17ClN4O2S/c21-14-2-3-18-15(6-14)13(10-28-18)8-25-9-17(24-11-25)16(20(26)27)5-12-1-4-19(22)23-7-12/h1-4,6-7,9-11,16H,5,8H2,(H2,22,23)(H,26,27)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.11E+3	n/a	n/a	n/a	n/a	7.4	25
Sanofi-Aventis Deutschland GmbH US Patent					Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...				US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4
					More data for this Ligand-Target Pair
Carboxypeptidase B (Homo sapiens (Human))	BDBM120783 (US8710232, 8) Show SMILES Nc1ccc(CC(C(O)=O)c2cn(cn2)C2CCNCC2)cn1 Show InChI InChI=1S/C16H21N5O2/c17-15-2-1-11(8-19-15)7-13(16(22)23)14-9-21(10-20-14)12-3-5-18-6-4-12/h1-2,8-10,12-13,18H,3-7H2,(H2,17,19)(H,22,23)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1.13E+3	n/a	n/a	n/a	n/a	7.4	25
Sanofi-Aventis Deutschland GmbH US Patent					Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...				US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4
					More data for this Ligand-Target Pair
C-X-C chemokine receptor type 2 (Homo sapiens (Human))	BDBM100345 (US8501981, 73) Show SMILES CC(C)(NC(=O)c1ccc2ccccc2c1OCCOc1ccc(F)c(Cl)c1)C(O)=O Show InChI InChI=1S/C23H21ClFNO5/c1-23(2,22(28)29)26-21(27)17-9-7-14-5-3-4-6-16(14)20(17)31-12-11-30-15-8-10-19(25)18(24)13-15/h3-10,13H,11-12H2,1-2H3,(H,26,27)(H,28,29)	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.25E+3	n/a	n/a	n/a	n/a	n/a	n/a
SANOFI US Patent					Assay Description CXCR2 inhibition using calcium fluorescence assay (FLIPR).				US Patent US8501981 (2013) BindingDB Entry DOI: 10.7270/Q24Q7SMB
					More data for this Ligand-Target Pair
Carboxypeptidase B (Homo sapiens (Human))	BDBM120794 (US8710232, 28) Show SMILES Nc1ccc(CC(C(O)=O)c2cn(Cc3cccc(Oc4ccc(F)cc4)c3)cn2)cn1 Show InChI InChI=1S/C24H21FN4O3/c25-18-5-7-19(8-6-18)32-20-3-1-2-17(10-20)13-29-14-22(28-15-29)21(24(30)31)11-16-4-9-23(26)27-12-16/h1-10,12,14-15,21H,11,13H2,(H2,26,27)(H,30,31)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1.44E+3	n/a	n/a	n/a	n/a	7.4	25
Sanofi-Aventis Deutschland GmbH US Patent					Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...				US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4
					More data for this Ligand-Target Pair
C-X-C chemokine receptor type 2 (Homo sapiens (Human))	BDBM100347 (US8501981, 166) Show SMILES CC(C)(NC(=O)c1ccc2ccccc2c1C#CCCCc1ccccc1)C(O)=O Show InChI InChI=1S/C26H25NO3/c1-26(2,25(29)30)27-24(28)23-18-17-20-14-9-10-15-21(20)22(23)16-8-4-7-13-19-11-5-3-6-12-19/h3,5-6,9-12,14-15,17-18H,4,7,13H2,1-2H3,(H,27,28)(H,29,30)	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.67E+3	n/a	n/a	n/a	n/a	n/a	n/a
SANOFI US Patent					Assay Description CXCR2 inhibition using calcium fluorescence assay (FLIPR).				US Patent US8501981 (2013) BindingDB Entry DOI: 10.7270/Q24Q7SMB
					More data for this Ligand-Target Pair
C-X-C chemokine receptor type 2 (Homo sapiens (Human))	BDBM100342 (US8501981, 46) Show SMILES CC(C)(NC(=O)c1sc2ccccc2c1OCCOc1ccccc1)C(O)=O Show InChI InChI=1S/C21H21NO5S/c1-21(2,20(24)25)22-19(23)18-17(15-10-6-7-11-16(15)28-18)27-13-12-26-14-8-4-3-5-9-14/h3-11H,12-13H2,1-2H3,(H,22,23)(H,24,25)	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.76E+3	n/a	n/a	n/a	n/a	n/a	n/a
SANOFI US Patent					Assay Description CXCR2 inhibition using calcium fluorescence assay (FLIPR).				US Patent US8501981 (2013) BindingDB Entry DOI: 10.7270/Q24Q7SMB
					More data for this Ligand-Target Pair
C-X-C chemokine receptor type 2 (Homo sapiens (Human))	BDBM100344 (US8501981, 55) Show SMILES CC(C)CC(C)(NC(=O)c1ccc2ccccc2c1OCCOc1ccccc1)C(O)=O Show InChI InChI=1S/C26H29NO5/c1-18(2)17-26(3,25(29)30)27-24(28)22-14-13-19-9-7-8-12-21(19)23(22)32-16-15-31-20-10-5-4-6-11-20/h4-14,18H,15-17H2,1-3H3,(H,27,28)(H,29,30)	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	2.56E+3	n/a	n/a	n/a	n/a	n/a	n/a
SANOFI US Patent					Assay Description CXCR2 inhibition using calcium fluorescence assay (FLIPR).				US Patent US8501981 (2013) BindingDB Entry DOI: 10.7270/Q24Q7SMB
					More data for this Ligand-Target Pair
C-X-C chemokine receptor type 2 (Homo sapiens (Human))	BDBM100346 (US8501981, 105) Show SMILES OC(=O)C1(CCC1)NC(=O)c1ccc2ccccc2c1OCCOc1ccc(F)cc1 Show InChI InChI=1S/C24H22FNO5/c25-17-7-9-18(10-8-17)30-14-15-31-21-19-5-2-1-4-16(19)6-11-20(21)22(27)26-24(23(28)29)12-3-13-24/h1-2,4-11H,3,12-15H2,(H,26,27)(H,28,29)	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	3.23E+3	n/a	n/a	n/a	n/a	n/a	n/a
SANOFI US Patent					Assay Description CXCR2 inhibition using calcium fluorescence assay (FLIPR).				US Patent US8501981 (2013) BindingDB Entry DOI: 10.7270/Q24Q7SMB
					More data for this Ligand-Target Pair
Carboxypeptidase B (Homo sapiens (Human))	BDBM120792 (US8710232, 25) Show SMILES Nc1ccc(CC(C(O)=O)c2cn(Cc3ccc(OC(F)(F)F)cc3)cn2)cn1 Show InChI InChI=1S/C19H17F3N4O3/c20-19(21,22)29-14-4-1-12(2-5-14)9-26-10-16(25-11-26)15(18(27)28)7-13-3-6-17(23)24-8-13/h1-6,8,10-11,15H,7,9H2,(H2,23,24)(H,27,28)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1.05E+4	n/a	n/a	n/a	n/a	7.4	25
Sanofi-Aventis Deutschland GmbH US Patent					Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...				US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4
					More data for this Ligand-Target Pair